Growing community of inventors

Denver, CO, United States of America

Phillip Reigan

Average Co-Inventor Count = 5.39

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Phillip ReiganDavid B Ross (7 patents)Phillip ReiganDavid T Ross (23 patents)Phillip ReiganMichael Fitzpatrick Wempe (7 patents)Phillip ReiganDan Theodorescu (7 patents)Phillip ReiganChao Yan (4 patents)Phillip ReiganSamy O Meroueh (3 patents)Phillip ReiganMartin A Schwartz (3 patents)Phillip ReiganDavid Ross (0 patent)Phillip ReiganPhillip Reigan (7 patents)David B RossDavid B Ross (28 patents)David T RossDavid T Ross (23 patents)Michael Fitzpatrick WempeMichael Fitzpatrick Wempe (14 patents)Dan TheodorescuDan Theodorescu (8 patents)Chao YanChao Yan (4 patents)Samy O MerouehSamy O Meroueh (9 patents)Martin A SchwartzMartin A Schwartz (6 patents)David RossDavid Ross (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Colorado (6 from 1,379 patents)

2. University of Virginia Patent Foundation (2 from 997 patents)

3. Indiana University (2 from 769 patents)

4. Other (1 from 832,680 patents)


7 patents:

1. 11964985 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

2. 11472812 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

3. RE48557 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

4. 10689392 - Anti-cancer compounds targeting ral GTPases and methods of using the same

5. 10676480 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

6. 10202397 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

7. 9353121 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…